T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Freshpet
FRPT
$2.61B
| $49M | 0.01% |
977,756
-1,470,487
| -60% | -$73.7M |
|
652
Primerica
PRI
$8.74B
| $49M | 0.01% |
396,620
-48,202
| -11% | -$5.95M |
|
653
SM Energy
SM
$3.14B
| $48.9M | 0.01% |
1,299,936
+331,890
| +34% | +$12.5M |
|
|
HZNP
654
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $48.9M | 0.01% |
789,755
-1,616
| -0.2% | -$100K |
|
655
Performance Food Group
PFGC
$16.3B
| $48.6M | 0.01% |
1,131,683
+83,082
| +8% | +$3.57M |
|
|
NARI
656
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $48.2M | 0.01% |
663,048
-1,303,254
| -66% | -$94.7M |
|
657
Zentalis Pharmaceuticals
ZNTL
$105M
| $48M | 0.01% |
2,217,740
-2,080,811
| -48% | -$45.1M |
|
658
Boyd Gaming
BYD
$6.84B
| $48M | 0.01% |
1,006,837
+4,870
| +0.5% | +$232K |
|
659
Scholar Rock
SRRK
$3B
| $47.9M | 0.01% |
6,908,142
-1,528,043
| -18% | -$10.6M |
|
660
Brookfield
BN
$100B
| $47.8M | 0.01% |
1,446,143
-703,653
| -33% | -$23.3M |
|
661
Aflac
AFL
$57.3B
| $47.8M | 0.01% |
850,504
-1,932
| -0.2% | -$109K |
|
662
Atkore
ATKR
$2.04B
| $47.7M | 0.01% |
613,228
+639
| +0.1% | +$49.7K |
|
663
Tenaris
TS
$18.5B
| $47.6M | 0.01% |
1,842,507
+1,781,007
| +2,896% | +$46M |
|
664
DuPont de Nemours
DD
$31.9B
| $47.5M | 0.01% |
941,551
-23,483
| -2% | -$1.18M |
|
665
Nurix Therapeutics
NRIX
$684M
| $47M | 0.01% |
3,606,352
-1,014,471
| -22% | -$13.2M |
|
666
Inspire Medical Systems
INSP
$2.33B
| $46.9M | 0.01% |
264,666
+25,737
| +11% | +$4.57M |
|
667
Entrada Therapeutics
TRDA
$199M
| $46.8M | 0.01% |
2,972,050
+534,552
| +22% | +$8.42M |
|
668
Deckers Outdoor
DECK
$16.9B
| $46.7M | 0.01% |
896,910
-4,527,954
| -83% | -$236M |
|
669
Zscaler
ZS
$43.4B
| $46.7M | 0.01% |
283,915
-3,942
| -1% | -$648K |
|
670
Curtiss-Wright
CW
$18.7B
| $46.6M | 0.01% |
335,098
+1,845
| +0.6% | +$257K |
|
671
Cboe Global Markets
CBOE
$24.5B
| $46.5M | 0.01% |
395,876
-4,567,174
| -92% | -$536M |
|
672
Aptiv
APTV
$17.8B
| $46.4M | 0.01% |
592,818
+1,686
| +0.3% | +$132K |
|
673
TopBuild
BLD
$11.8B
| $46.1M | 0.01% |
280,033
-21,314
| -7% | -$3.51M |
|
674
Realty Income
O
$54.4B
| $46M | 0.01% |
790,695
+14,601
| +2% | +$850K |
|
675
Landstar System
LSTR
$4.5B
| $46M | 0.01% |
318,553
-1,206,792
| -79% | -$174M |
|